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ABSTRACT The pufferfish Fugu rubripes has a genome
'7.5 times smaller than that of mammals but with a similar
number of genes. Although conserved synteny has been dem-
onstrated between pufferfish and mammals across some
regions of the genome, there is some controversy as to what
extent Fugu will be a useful model for the human genome, e.g.,
[Gilley, J., Armes, N. & Fried, M. (1997) Nature (London) 385,
305–306]. We report extensive conservation of synteny be-
tween a 1.5-Mb region of human chromosome 11 and <100 kb
of the Fugu genome in three overlapping cosmids. Our find-
ings support the idea that the majority of DNA in the region
of human chromosome 11p13 is intergenic. Comparative
analysis of three unrelated genes with quite different roles,
WT1, RCN1, and PAX6, has revealed differences in their
structural evolution. Whereas the human WT1 gene can
generate 16 protein isoforms via a combination of alternative
splicing, RNA editing, and alternative start site usage, our
data predict that Fugu WT1 is capable of generating only two
isoforms. This raises the question of the extent to which the
evolution of WT1 isoforms is related to the evolution of the
mammalian genitourinary system. In addition, this region of
the Fugu genome shows a much greater overall compaction
than usual but with significant noncoding homology observed
at the PAX6 locus, implying that comparative genomics has
identified regulatory elements associated with this gene.
The pufferfish Fugu rubripes has a compact genome of 400 Mb,
some 7.5 times smaller than that of mammals but with a similar
number of genes. This compaction is caused by intron sizes
being smaller as well as much reduced intergenic distances, i.e.,
distances between transcription units. For this reason, Fugu
has been proposed as a model organism to study genes both at
the level of the individual gene and in a genomic context (1, 2).
The Fugu genome exhibits homology with other species across
critical regulatory segments of some genes (3), and it has been
established that synteny is conserved across a number of small
regions between pufferfish and mammals. To date, linkage of
two or three genes has been demonstrated for certain synteny
groups such as FOSyS31iii125ys20i15 (4), PDGFRbyCSF1R
(5), MAP-2yMYL-1yCPSIII (6), and TSC2yPKD1ySSTR5 (7)
although these examples consist of a limited number of genes
covering relatively small distances in terms of human DNA.
Additionally, these studies did not provide complete Fugu
DNA sequence. It is becoming apparent that not all regions of
the human genome are suitable for modeling in Fugu; for
example, even the tightest mammalian gene cluster, that of the
surfeit genes, does not exhibit complete conservation of
synteny between mammals and Fugu (8). With accelerating
progress in the Human Genome Project, the biological impor-
tance of long range genomic organization is now beginning to
emerge, and it is important that conservation of synteny,
genomic organization, and noncoding sequence homology be
identified across vertebrate species to explore genomic func-
tion.
We chose to investigate possible conservation of synteny
between Fugu and the 11p13 region of the human genome for
several reasons: (i) The human region contains two well
studied disease genes, PAX6 and WT1, each of which is
essential for normal mammalian development. Their heterozy-
gous deletion gives rise to WAGR syndrome - Wilms’ tumor,
Aniridia, Genitourinary abnormalities, and mental Retarda-
tion (9). PAX6 and WT1 are conserved through evolution, can
generate several different protein isoforms, and have complex
regulatory systems, which orchestrate tissue-specific and tem-
porally regulated expression patterns. Certain forms of
aniridia arise as a result of a translocation outside the PAX6
gene presumably through a ‘‘position effect’’ (10) and it is
thought that both WT1 and PAX6 use long-range genetic
regulatory elements. Therefore, a study of this region should
lead to a greater understanding of the structure and regulation
of these complex, developmentally important human disease
genes; (ii) There are several well characterized mouse mutants
in this region, both at specific gene loci (11, 12) and deletions
up to several megabases (13, 14), which will facilitate in vivo
functional analyses by gene replacementycomplementation
studies in the mouse; (iii) There is extensive coverage of this
region in both human and mouse with YACyPAC contigs (15)
although the associated gene maps are not complete. This will
allow the degree of synteny to be accurately assessed while
allowing the assembly of better gene maps across this region;
(iv) Other human disease-associated loci, e.g., those associated
with loss of heterozygosity in breast and bladder cancers (16),
mapping to this region may be defined through homology
studies. In addition, the cause(s) of mental retardation asso-
ciated with WAGR deletions has yet to be determined. (v)
Sequencing of 225 kb of the human PAX6 region has been
completed [http:yywww.sanger.ac.ukycgi-binyhummap-
?map 5 Chro11 misc] and that of the WT1 region is underway,
allowing direct ‘‘base-by-base’’ comparisons to be made.
The PAX6 and WT1 genes are separated by approximately
750 kb in the human genome. Recently, a human homolog of
reticulocalbin (RCN1) was identified at a CpG island site
between WT1 and PAX6 (14), thereby providing another
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reference point with which to compare Fugu. If this region
shows synteny conservation and the expected level of com-
paction for the Fugu genome, a search for new genes and for
long distance regulatory elements within 11p13 could be
undertaken by using comparative genomics in addition to
allowing detailed studies of the structure and regulation of
individual genes.
METHODS
The Tetraodon fluviatilis probe was generated by degenerate
PCR of 50 ng of genomic DNA, by using the following
oligonucleotide primer pair (59-39): exon 8 (sense) CAG TGT
GA(CyT) TT(CyT) A(AyC)(AyG) GAC TG and exon 10
(antisense) GT(TyC) TCT (CyT)TG (GyA)TG CAT (Gy
C)TT CTG.
The reaction profile of the PCR consisted of an initial 5-min
denaturation at 94°C, followed by 30 cycles of 10 s at 94°C, 45 s
at 50°C, 2 min at 72°C with a final extension step of 10 min at
72°C.
PCR products of '900 bp were subcloned and sequenced to
verify clones corresponding to WT1. A gridded cosmid library
of Fugu rubripes genomic DNA [Greg Elgar, Human Genome
Mapping Project Resource Centre (HGMP-RC)] was probed
with the pufferfish (Tetraodon fluviatilis) WT1 genomic frag-
ment (exon 8-exon 10) at high stringency.
Sequence analysis of cosmid 151-J19: Cosmid DNA was
sonicated and ligated into EcoRV digested pBluescript. Re-
combinants were PCR amplified with limiting dilutions of
dNTPs and primers. PCR products were sequenced by using
dye terminator chemistry on an Applied Biosystems 377
sequencer. Gaps were filled in by using walking primers. All
coding sequence has been sequenced in both directions, and all
regions have been covered by at least two independent clones.
Assembly was performed by using SEQMAN (DNAStar). Se-
quence analysis was performed by using CLUSTAL W (17)
alignments, and DOTTER for Fugu:human genomic DNA com-
parisons (18).
PCR sequencing was used to verify the presence of amino
acids KPS in multiple cosmid clones and independent samples
of Fugu rubripes genomic DNA. The probes used for this were:
sense oligo (59-39) CTG TGA AAC CTC CAC CAC and
antisense oligo (59-39) GAG TGA TTT CAG CTC CAG.
Reaction conditions were 5-min denaturation at 94°C, fol-
lowed by 30 cycles of 5 s at 94°C, 30 s at 58°C, 30 s at 72°C, and
a final 5-min elongation step at 72°C. The resulting 240-bp
PCR products were directly sequenced by using the Sequenase
kit as directed by the manufacturer.
RESULTS AND DISCUSSION
To provide an entry point for analysis of the Fugu homolog of
the WAGR region, we screened the HGMP Fugu cosmid
library (Greg Elgar, HGMP-RC) by using a PCR-generated
genomic Tetraodon WT1 probe. One cosmid, 151J19, was
selected for further analysis because it contained the largest
Fugu insert. Sequence scanning demonstrated, in addition to
WT1, the presence of Fugu homologs of both RCN1 and PAX6
on this cosmid. As the gene content of this Fugu cosmid
corresponded well to the WAGR region, we decided to
sequence 151J19 in its entirety to allow comparison with
human and other species data for the region. Cosmid 151J19
contains 45,565 bp of Fugu DNA with the 59 end of the WT1
exon 1 at base 191 and of PAX6 exon 12 at base 44,736. As in
FIG. 1. (A) Scale representation of the human chromosome 11p13 region encompassing the WT1, RCN1, and PAX6 genes compared with the
equivalent genomic region in Fugu cosmids. Colored boxes indicate the positions of the three genes relative to each other in the two genomes. Genes
in the reverse orientation are marked below the sequence line. Fugu cosmid 151J19 has been completely sequenced (see text), and the approximate
positions of two overlapping Fugu cosmids are indicated. The two overlapping cosmids have been sequence scanned. Cosmid 038E12 contains a
sequence (ne) homologous to a NotI end clone (NE, GenBank accession no. HSMFRAI) lying 500 kb from the WT1 gene in man. There is an
expressed sequence tag cluster (B) 6 kb 39 of the human PAX6 gene, which has a Fugu homolog (b) found on cosmid 127B01. (B) Detailed diagram
of Fugu cosmid 151J19. Fugu genomic DNA (45,565 kb) is represented. WT1 and PAX6 are transcribed in the forward direction whereas RCN1
is transcribed from the reverse strand. The complete coding sequence of the WT1 gene is represented by the nine blue exons, RCN1 by six green
exons, and PAX6 by the first 12 exons in red. The last exon of PAX6 (exon13) is not present on this cosmid clone. A ‘‘1’’ on top of an exon indicates
that this exon is alternatively spliced in man. Human genomic sequence is available across the human PAX6 gene, and this is represented by
HSCFAT5 and HSA1280. Additional regions of DNA similarity between human and Fugu is indicated by yellow boxes. (C) Exon structure of the
Fugu PAX6 gene. The human PAX6-coding region (represented in blue) starts toward the end of exon 4, with exons 1–3 being entirely noncoding.
Fish (including the blind cavefish and zebrafish) have additional coding sequences located in exon 2, exon 4, and exon 4a (yellow), which combine
with the blue exons to form a series of additional isoforms. Note that the beginning of the Fugu-coding sequence results from the splicing together
of exons 2 and 4, skipping exon 3.
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FIG. 2. (A) Clustal alignment of WT1 genes from human, mouse, Xenopus, and Fugu. Exons are numbered and their boundaries marked by
a vertical line in all three alignments. Both Xenopus and Fugu genes lack the polyproline tract in the middle of exon 1 and the whole of the
alternatively spliced exon V. The alternative splice donor sites at the end of exon IX are marked by open circles on the boundary markers.
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the human genome, the Fugu RCN1 gene is transcribed in the
opposite direction to its neighbors, demonstrating conserva-
tion of both gene order and orientation between Fugu and
mammals. Screening of the HGMP Fugu cosmid library with
probes isolated from 151J19 resulted in the isolation of over-
lapping cosmids at each end (Fig. 1). Analysis of the PAX6
overlapping cosmid has located part of the Fugu homolog of a
putative gene (expressed sequence tag contig) telomeric to
PAX6. The WT1-overlapping cosmid has revealed homology
with a human CpG island expressed sequence tag (19) map-
ping '500 kb centromeric to WT1. The size reduction of this
region in Fugu compared with man is 15-fold, with Fugu
sequences in three contiguous cosmids covering '1.5 Mb of
the human genome. More importantly, the relative positions of
five genes has been conserved between Fugu and man thereby
fixing these loci and enabling the intervening sequences to be
directly compared as they become available. These data pre-
dict that RCN1 may be the only gene between PAX6 and WT1
in the human genome, leaving .600 kb of DNA between
transcription units. Until the complete sequence of human
11p13 becomes available, the presence of other genes between
WT1 and PAX6 remains a possibility. To date, however, despite
intense study (15, 19–21), no other genes have been found in
this region in man. It is interesting that the Fugu homolog of
this human region, which exhibits a low density of CpG islands,
shows greater than average size reduction, consistent with
Fugu counterparts of gene-poor regions exhibiting the greatest
compaction (2). The complete sequencing of this Fugu region
will facilitate studies probing the function of noncoding DNA
in gene sparse regions of the human genome. Given that
known gene order and orientation across 1.5 Mb has been
conserved, this example provides the most compelling evi-
dence to demonstrate the validity of the Fugu genome project
away from the context of gene families.
The Fugu WT1, RCN1 and PAX6 genes show very high
similarity to their well-characterized human orthologs. The
intronyexon organization of both the WT1 and PAX6 genes is
conserved and that of the reticulocalbin gene has been pre-
dicted (Fig. 2) to be the same as in the mouse. The Fugu PAX6
gene also contains a homolog of the alternatively spliced
human exon 5a (Fig. 2), although this exon in Fugu consists of
12 amino acids instead of the 14 amino acids found in other
vertebrates. Comparisons with PAX6 cDNA sequences from
zebrafish (22) and the blind cavefish Astyanax (23) suggest that
the fish proteins can initiate upstream of the mammalian ATG
site to generate an N-terminal extension, which would involve
skipping the Fugu sequence homologous to the noncoding
mammalian exon 3 (Fig. 1C).
The human WT1 gene has the potential to generate 16
different protein isoforms by a combination of alternative
splicing, RNA editing, and alternative translational start site
usage (24). We predict that the Fugu WT1 gene can generate
only two different isoforms by the introduction of three amino
acids between the two most C terminal zinc fingers (Fig. 2).
The retention of this alternative splice implies that WT1 could
play a dual role in both transcription and RNA processing in
nonmammalian, as well as mammalian, vertebrates (25). In
Fugu, this amino acid triplet consists of KPS (verified in several
independent cosmid clones and samples of Fugu rubripes
genomic DNA, not shown) in contrast to all other known WT1
homologs where it is KTS. The change from threonine to
proline converts a noncharged polar amino acid to a non-
charged nonpolar amino acid. Given the general level of amino
acid conservation of the zinc finger region of Fugu WT1 and
the conservation of the alternative splice donor and acceptor
sequences, it would appear that the 63 amino acid alternative
splice is functional in Fugu and that this function is not strictly
reliant on KTS. The role of the 6KPS alternative splicing
could be to generate protein isoforms with different target-
binding abilities by altering the spacing of zinc fingers 3 and 4.
Fugu WT1 lacks the 17 amino acid exon 5, consistent with this
feature being mammalian-specific (26). Mammalian WT1
translation can initiate at a CTG codon, adding 68 amino acids
to the N terminus of the protein (27). The sequence upstream
of the ATG codon in Fugu shows no evidence of an alternative
start site resembling that found in mammals, suggesting this
may represent another mammalian specific isoform. The final
element creating the diversity of human WT1 proteins is RNA
editing (28), which results in an amino acid change at position
281 from leucine to proline. Intriguingly, the Fugu genome
encodes a proline at position 281 (Fig. 2). The cloning of the
Fugu WT1 gene opens up the possibility of investigating the
evolution of genitourinary development at a functional level in
terms of both evolving protein structure and the regulation of
FIG. 3. (A) Dot plot alignment of cosmid 151J19 (x axis) with
human genomic sequence HSA1280 (y axis) from the human PAX6
region. The program DOTTER was used to align the sequences with a
window size of 21. Regions of similarity are identified as a concen-
tration of dots (identical bases) generating a line. Exonic regions of
similarity are marked by numbers. Three other regions of high DNA
similarity also are marked (i–iii). (B) The weakest of these is magnified
by using the DOTTER program, and a nucleotide alignment across this
region is represented in C, which illustrates the lack of third base
‘‘wobble’’ associated with these noncoding segments of homology
between Fugu and man.
(B) Clustal alignment of mouse, human, and Fugu RCN1 genes. Intronyexon boundaries are marked for Fugu as these are not published for the
mouse or human genes. It is likely that the mammalian genes have a very similar or identical genomic organization. (C) Clustal alignment of PAX6
genes from Fugu, blind cavefish, zebrafish, Xenopus, mouse, and human. In the three fish species shown, there are additional coding sequences at
the 59 end of the gene giving rise to a variety of transcripts. The most 59 transcripts in fish are formed by splicing together exons II and IV, skipping
exon III. There is also an additional exon found in cavefish and (by homology) Fugu that has not been found in higher vertebrates and does not
appear to be present in human genomic sequence for this region (HSCFAT5 and HSA1280). Exon 13 has not yet been sequenced in Fugu.
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gene expression, i.e., to what extent the evolution of WT1
protein isoforms and genetic regulatory elements have con-
tributed to the evolution of the mammalian genitourinary
system.
To test the usefulness of Fugu for identifying conserved
regulatory elements, we performed dot plot analyses between
Fugu PAX6 and the corresponding human genomic sequence
(Fig. 3). Several noncoding, potential regulatory, sequences
were identified, which are represented in homologous genomic
positions along the genome in Fugu and in man. The first two
clusters of these regions are .5 kb 59 of the noncoding exon
1 of human PAX6. The third, most highly conserved, region is
the proposed retinal specific enhancer (29) in intron 4, while
a fourth conserved noncoding cluster lies in intron 7 (Fig. 3),
the largest intron in both Fugu and man. Human intron 7 has
the features of a CpG island, suggesting the possible presence
of another gene; however, none of the sequences conserved
between Fugu and man, nor any neighboring tracts, reveal
ORF. The lack of ‘‘wobble’’ at what might be the third position
of the triplet codon also suggests a regulatory function for
these sequences. We are considering the possibility that these
sequences may constitute an alternative start site, which would
give rise to a PAX6 isoform lacking a paired domain. A similar
paired domain lacking PAX6 product has been found at the
genetic locus mab-18 (male abnormal) in C. elegans (30) as an
alternative form to the full length protein observed in vab-3
chemotactic mutants (31). N-terminally truncated forms of
PAX6, lacking the paired domain, also have been reported in
quail (32). By comparing genomic data from species as diver-
gent as Fugu and man in this way, it has been possible to
identify a number of conserved regions, with characteristics of
regulatory elements, which may now be studied further to
assess their role in gene expression and function.
In conclusion, we have demonstrated conserved synteny
between Fugu and 1.5 Mb of human chromosome 11p13—a
region where the identified genes are not members of gene
families and yet their order and orientation is not scrambled
compared with Fugu. There are important implications of such
a finding for the comparative analysis of a large genomic
region, given that the full human chromosome 11p13 sequence
of '15 Mb may be available soon and excellent biological
resources exist for functional studies in several animal species
as well as in cell culture. Despite near complete coverage of
this region with human YACyPAC contigs, the identification
of genes remains difficult, although there is some evidence
(such as relatively low CpG island density) that there may be
few genes in this region. This study suggests that it will now be
possible to use comparative genomics between Fugu and man
to assist the designation of new genes and the identification of
regulatory elements and, more fundamentally, increase our
understanding of the nature of large segments of intergenic
DNA in the human genome.
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